ArticleThe Laryngoscope2025
Apolipoprotein E (APOE) Genotype and Cognitive Outcomes of Snoring in a Large Cohort of Adolescents.
Article in The Laryngoscope, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Apolipoprotein E (APOE) Genotype and Cognitive Outcomes of Snoring in a Large Cohort of Adolescents.The Laryngoscope · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
Abstract
objectiveThe objective of this study is to investigate whether apolipoprotein E (APOE) ε4 genotype is associated with lower cognitive performance in children with habitual snoring and to determine if APOE could stratify children with snoring by their risk for adverse cognitive outcomes.
methodsWe performed a secondary analysis of the Adolescent Brain Cognitive Development (ABCD) dataset, which included approximately 12,000 children aged 9-10 years recruited between June 2016 and October 2018, with follow-up data from years 1 and 3. Cognitive performance was assessed using the National Institutes of Health Toolbox (NIH-TB) Cognitive Battery. Snoring frequency was evaluated using the Sleep Disorders Scale for Children and categorized as none, non-habitual (< 3 nights/week), or habitual (≥ 3 times/week). APOE genotypes were identified using Plink 2.0. Linear mixed effects models examined interaction effects between APOE genotypes, time, and snoring on age-adjusted Crystallized Cognition Composite scores, adjusting for demographic and clinical variables. Secondary outcomes included other NIH-TB domain scores.
resultsOf 11,725 children (52.2% female) in year 1, 6.9% were habitual snorers. APOE genotype distribution was 69.8% ε3ε3, 2.7% ε3ε4/ε4ε3, and 27.5% ε4ε4. No significant interaction effects were found between genotype and snoring or between genotype, snoring, and time. Significantly, the APOE genotype did not modify the relationship between the frequency of snoring and the NIH-TB Crystallized Composite score, either at a single point or over time.
conclusionAPOE genotype was not associated with worsening cognition in habitually snoring children over time. More extended follow-up periods may be necessary to detect potential chronic cognitive decline in this population. LEVEL OF EVIDENCE: 3:
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.